$ROIV
Roivant Sciences Ltd. Common Shares
XNAS•Health Care•Pharmaceutical Preparations
$35.80
▲+0.06%+$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRoivant Sciences Ltd. Common Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is ROIV up today? It is at $35.80 (+0.06%), and our scanner flagged it 145 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ROIV spikes, and full due diligence on ROIV — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ROIV 145 times in the last 30 days. Create a free account to track $ROIV, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ROIV from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ROIV today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystShareholder Vote, from an SEC filing. Read it →Latest filingSC 13D/AActivist 5%+ stake updatedOct 6, 2026 · todaySources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Venker Eric Officer | Sold (automatic/other) | -200K 0.03% of company | sold 11% | 1.60M | $7.3M at $36.62 | Sep 30, 26 |
Venker Eric Officer | Other | 200K 0.03% of company | added 13% | 1.80M | $770K at $3.85 | Sep 30, 26 |
Sukhatme Mayukh Officer | Sold (automatic/other) | -47K | sold 0.3% | 18.58M | $1.7M at $36.57 | Sep 30, 26 |
Torti Frank Officer | Acquired (grant/award) | +40K | added 0.3% | 13.50M | $1.5M at $36.57 | Sep 30, 26 |
Gline Matthew Officer | Sold (automatic/other) | -76K 0.01% of company | sold 0.5% | 16.58M | $2.8M at $36.57 | Sep 30, 26 |
Pulik Richard Officer | Sold (automatic/other) | -2K | sold 0.8% | 270K | $85K at $39.77 | Sep 20, 26 |
Humes Jennifer Officer | Sold (automatic/other) | -4K | sold 3.5% | 106K | $154K at $39.77 | Sep 20, 26 |
Epperly Melissa B, Director | Acquired (grant/award) | +5K | added 51% | 15K | n/a | Sep 16, 26 |
Fitzgerald Meghan Director | Acquired (grant/award) | +5K | added 14% | 41K | n/a | Sep 16, 26 |
Momtazee James C Director | Acquired (grant/award) | +5K | added 4.7% | 112K | n/a | Sep 16, 26 |
Oren Ilan Director | Acquired (grant/award) | +5K | added 4.3% | 124K | n/a | Sep 16, 26 |
Gold Daniel Allen Director | Acquired (grant/award) | +5K | added <0.1% | 8.97M | n/a | Sep 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ROIV from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ROIV today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ROIV last traded at $35.80, up 0.06% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Roivant Sciences Ltd. Common Shares (ROIV) is next expected to report earnings on Monday, November 9, 2026, about 34 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ROIV Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ROIV 145 times in the last 30 days.
ROIV (Roivant Sciences Ltd. Common Shares) trades on XNAS, with a market cap of about $25.84B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ROIV for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ROIV discussion
Sign in to ask a question or join the discussion.